Skip to main content

Site notifications

Kadmon Oceania Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

1 result(s) found, displaying 1 to 1
  • New AusPAR for Rholistiq (belumosudil) for the treatment of patients with chronic graft-versus-host disease aged 12 years and older.

Help us improve this page